Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer
Open Access
- 7 October 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (19) , 10781
Abstract
Triple-negative breast cancer (TNBC) is a challenging subtype of breast cancer characterized by the absence of estrogen and progesterone receptors and HER2 expression, leading to limited treatment options and a poorer prognosis. TNBC is particularly prevalent in premenopausal African-descent women and is associated with aggressive tumor behavior and higher metastatic potential. Tumor-associated macrophages (TAMs) are abundantly present within the TNBC microenvironment and play pivotal roles in promoting tumor growth, progression, and metastasis through various mechanisms, including immune suppression and enhancement of angiogenesis. This review provides an in-depth overview of TNBC, focusing on its epidemiology, its molecular characteristics, and the critical influence of TAMs. It discusses the pathological and molecular aspects that define TNBC’s aggressive nature and reviews current and emerging therapeutic strategies aimed at targeting these dynamics. Special attention is given to the role of TAMs, exploring their potential as therapeutic targets due to their significant impact on tumor behavior and patient outcomes. This review aims to highlight the complexities of the TNBC landscape and to present the innovative approaches that are currently being pursued to improve therapeutic efficacy and patient survival.Keywords
This publication has 177 references indexed in Scilit:
- The Interaction between Macrophages and Triple‐negative Breast Cancer Cells Induces ROS‐Mediated Interleukin 1α Expression to Enhance Tumorigenesis and MetastasisAdvanced Science, 2023
- Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell linesJournal of Cancer Research and Clinical Oncology, 2021
- Research trends in pharmacological modulation of tumor‐associated macrophagesClinical and Translational Medicine, 2021
- Checkpoint inhibitors in triple‐negative breast cancer (TNBC): Where to go from hereCancer, 2018
- The new TNM-based staging of breast cancerVirchows Archiv, 2018
- Health Disparities and Triple-Negative Breast Cancer in African American WomenJAMA Surgery, 2017
- Identification and use of biomarkers in treatment strategies for triple‐negative breast cancer subtypesThe Journal of Pathology, 2013
- Characteristics Associated With Differences in Survival Among Black and White Women With Breast CancerJAMA, 2013
- Higher population‐based incidence rates of triple‐negative breast cancer among young African‐American womenCancer, 2011
- Reproductive and hormonal risk factors for postmenopausal luminal, HER‐2‐overexpressing, and triple‐negative breast cancerCancer, 2008